Search results

The European medical cannabis sector is experiencing unprecedented growth, driven by progressive legislation, expanding patient access, and a maturing supply chain, according to a new report. Findings from The European Cannabis Report: 10th Edition, published today (Tuesday 29 July), reflect a...

Current methods used by police to detect drug driving are not based on science, say the authors of a new paper calling for an overhaul of cannabis impairment testing. As cannabis becomes legal in a growing number of US states, public safety experts have raised concerns about the lack of...

In a special edition of the Business of Cannabis Podcast, we go from ‘anecdote to evidence’ with Dr Anne Katrin Schlag, Head of Research and Interim CEO at Drug Science, and Graham Woodward, Chief Operating Officer at Releaf. Together, they explore how the UK can move from anecdotal patient...

Over four years after its slated launch, the NHS Cannabis Patient Registry is set to publish its first data. The years of obfuscation and delay prompted a Freedom of Information request by Business of Cannabis, which has established that the NHS will publish data from its ‘registry’ by the ‘end...

By Dr Sue Clenton, Medical Director, Rupa Shah, Chief Legal and Compliance Officer, and Graham Woodward, Chief Operations Officer, Releaf In a healthcare landscape as tightly regulated as the UK’s medical cannabis sector, building a clinical team isn’t just operational work, it’s...

A new clinical trial will investigate the potential of cannabis-based treatment to improve quality of care for hospice eligible patients with dementia. The University of Maryland School of Medicine (UMSOM) Palliative Medicine Program has launched a new clinical trial funded by the National...

Research from two separate studies has highlighted how promotional packaging and social media content can make cannabis-infused products more appealing to teens, prompting calls for more effective regulations. Bright colours, fruit imagery, and labels like “locally made” or “vegan” when used on...

Patients have called for Switzerland’s new cannabis laws to address ‘unsatisfactory’ medical access ahead of an upcoming consultation on the draft legislation. As legislators look to make further reforms to Switzerland’s cannabis laws, campaigners are urging them to consider the daily realities...

In the first controlled clinical trial of CBD in boys with autism, two-thirds of participants showed behavioural improvements with treatment, but there was also a significant placebo effect. Researchers at the Center for Medicinal Cannabis Research at University of California San Diego School...

The UK’s Food Standards Agency (FSA) has announced some significant updates to its multi-year CBD Novel Foods approvals process, finally offering hundreds of long-suffering businesses some light at the end of the tunnel. Following suggestions from the FSA late last year that it planned to...

Words by Dr Sue Clenton, Medical Director, Releaf Over the past year, we’ve seen medical cannabis move from the margins toward the mainstream — not through media headlines or marketing campaigns, but in clinics, in consultations, and in the steady accumulation of patient outcomes. At Releaf...

Patients in Australia living with endometriosis say cannabis is more-effective for managing their symptoms, and has fewer side-effects than pharmaceutical medications, a new survey finds. According to new survey data published in the journal Reproduction & Fertility, the majority of patients...

Ukraine has officially issued its first ever permit for medical cannabis to be imported into the country, bringing patients one step closer to receiving treatment. It represents the latest development in Ukraine’s nascent but rapidly evolving medical cannabis programme, after the country...

A profound change is quietly occurring across the UK, writes James Smith, medical cannabis patient and co-founder of 4C Labs, following a recent experience using cannabis-based medicines to recover from major hip surgery on the NHS. Disclaimer: I am not a doctor or a scientist, this story is...

A new UK study highlights how medical cannabis may improve quality of life for people living with obsessive compulsive disorder (OCD). Researchers at Drug Science analysed data from what they believe to be the largest sample of OCD patients receiving cannabis-based medicines on prescription...

Two cannabis-derived compounds have shown remarkable effectiveness against fungal pathogens in laboratory tests, according to new research. In a study published in The Journal of Neglected Tropical Diseases (PLOS NTDs), researchers discovered that Cannabidiol (CBD) and Cannabidivarin (CBDV)...

The UK government has commissioned the Advisory Council on the Misuse of Drugs (ACMD) to carry out a formal review of the current state of play regarding cannabis-based medicinal products. Seven years since the first unlicensed cannabis-based medicinal products (CBPMs) were prescribed in the...

The Czech Republic’s Chamber of Deputies has approved a landmark amendment which, if passed through the Senate, will legalise home cultivation of up to three plants, home possession of up to 100g of cannabis per person, and public possession of up to 25g per person. Its initial passage by an...

Cannabis use among older adults in the US has reached a new high, with 7% of adults aged 65 and over who report using it in the past month. This is according to an analysis led by researchers with the Center for Drug Use and HIV/HCV Research (CDUHR) at the NYU School of Global Public Health...

Words by Dr Sue Clenton, Medical Director, Releaf If we are serious about the future of medical cannabis in the UK, we must be equally serious about its clinical foundations. That means investing not just in science or access, but in a new generation of confident, well-informed prescribers...